Introduction
Cystic fibrosis (CF) is the inherited chronic disease most common among Caucasians (1) and affects one in every 2,500 Europeans, with a similar incidence in Brazil (2) . It is a congenital and multi-systemic disease that affects the mucus production of exocrine glands, which become thick and obstruct the channels in which it is secreted (1) . This manifestation can occur in numerous epithelial cells including sweat, pancreatic and bile ducts, airways, intestinal and deferent vessels (3) .
There are several clinic manifestations due to the CF genetic characteristic with more than 1,000 acknowledged mutations so far, though there is always a triad of symptoms in the pulmonary and digestive tracts and in the sweat glands (1) .
The treatment has to be delivered several times a day (4) . The possibility of treating patients at home allows them to go places and perform tasks common to people in the same age group (5) .
The CF can be considered a stigmatizing disease because it marks those who live with it. There is body deformity caused by the evolution of the disease, which marks the body in a characteristic way, including producing a barrel chest and clubbing of the feet.
Additionally, there are daily and constant care rituals, which oftentimes impede children and adolescents from performing activities common to their age group (6) .
Considerations of stigma
We understand that stigma is a situation in which the individual is not fully socially accepted. This term was created by the Greeks to indicate something bad in the moral status of those who were stigmatized and is translated as a bodily mark. It is profoundly depreciatory and distinguishes an individual from others who are in a certain social category (7) .
There are three types of stigma: the body stigma, moral and tribal race stigma and that of nation or religion. The majority can be immediately perceived through an individual's stereotype, which causes the individual to become discredited, while other types of stigma can be hidden and are not perceptible in a first contact, which causes the individual to become discreditable. This difference is crucial to the way one copes with stigma (7) .
A stigma is based on differences, that is, on 
.
Cystic Fibrosis: a Stigmatizing Disease
The impact of the stigma related to CF is especially critical during childhood and adolescence because these are periods when social relationships and the individuals' identity are formed.
Because CF is a congenital disease and is most often diagnosed during childhood, many children with CF start to quantify their differences. For example, they realize, only by being in contact with their peers, that they are smaller and thinner than their peers, that they cough and become tired more easily, and thus the school environment is frequently the landmark of their experience with their chronic disease (5, (8) (9) (10) .
Physical differences are not the only reason children with CF become stigmatized. The differences in these children's daily routine caused by the disease symptoms and treatment also contribute to making them different and consequently stigmatized (9) (10) (11) .
Children with CF can become confused by the way their peers respond to their differences and do not understand the meaning others attribute to the disease symptoms. The fear of not being accepted leads to anxiety and fear of social interactions (10) .
Although stigma and being transmittable are distinct concepts, they come together in the case of disease and the stigma is seen as something contagious and the contagion as something stigmatizing. This union of concepts highlights that the social course of the disease can result from its biological course, thus, one notion reinforces the other (12) .
Even though CF is not a transmissible disease, it
can have the same impact, as if it was transmittable, in mixed contacts. The fact that the disease has a visible symptomatology, such a cough and expectoration, has an immediate impact on interpersonal relationships and is related to the issue of being transmittable, reinforcing shame and fear of stigma (9, 11) .
One of the ways used to minimize the stigma associated with the disease is concealment (7) . Some studies (6, (9) (10) have shown that oftentimes disclosing the disease, which is seen as a secret, is reserved only for those closest, such as best friends.
Circumventing the treatment is not only a way to avoid other people learning about the disease but also a way to forget, for a while, that the disease exists. It is a way of normification (5, 11) .
The differences related to CF can lead, especially for adolescents, to seek new bases of comparison and closeness among those that share the stigma (1, 13) . In addition to helping to reduce the perception of being different, meeting other people with CF makes them feel less lonely and share experiences (8) .
The formation and search for groups of people who share a stigma is one of the available means of coping with stigma. Studies show that sharing information, feelings, concerns and even similar characteristics of people with CF and their family members is one of the social supports most expected and significant for these people (11, 14) .
Families of children and adolescents with CF also share the feeling of being different when they compare their lives with those of other families with healthy children (8) . This feeling was described in studies with families of children with chronic diseases, such as those dependent on mechanical ventilation at home (15) .
In addition to children and adolescents with CF, their families can also become socially isolated due to the constant care they have to deliver to their children (14) , which causes distancing from other social functions such as work (16) .
Final Considerations
Cystic fibrosis is considered a stigmatizing disease Similar results were found in a study of adolescents with HIV/AIDS (16) , which corroborates the considerations presented here, that knowledge of the disease stigma is relevant to plan care, evaluation of treatment adherence and to promoting quality of life of children and adolescents with chronic diseases.
